eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 69
Original paper

Primary ameloblastic carcinoma: literature review with case series

Sarah Ahmed Mohamed Mahmoud, Hatem Wael Amer, Sally Ibrahim Mohamed

Pol J Pathol 2018; 69 (3): 243-253
Online publish date: 2018/11/20
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Ameloblastic carcinoma (AC) is an extremely rare malignant odontogenic tumour arising from odontogenic epithelium. It was classified into primary type and secondary type. A previous study revealed that primary ameloblastic carcinoma cases were associated with more favourable prognosis than secondary cases. The aim of the present work was: to report the clinical, histopathological, immunohistochemical, and ploidy status, and therapeutic details of four cases of primary AC, and to review the literature with regard to clinical, follow-up, prognosis, histopathological, and immunohistochemical information of primary AC. The Medline database was searched using the term ameloblastic carcinoma and primary type. The review of English literature revealed that primary ameloblastic carcinoma favours the posterior mandible with profound male predilection and appears as an ill-defined radiolucency. Metastasis and invasion are more likely to occur in maxillary cases. The treatment of choice is wide surgical resection with or without cervical lymph node dissection. Adjuvant postoperative radiotherapy is beneficial in incomplete resection cases and advanced soft tissue invasion. The most specific diagnostic methods of AC, as concluded from review, are α-SMA in epithelial cells in conjunction with Ki-67 index value and SPF more than 11.5%.

ameloblastic carcinoma, case series, primary type, review

Kallianpur S, Jadwani S, Misra B, et al. Ameloblastic carci-noma of the mandible: Report of a case and review. J Oral Maxillofac Surg Med Pathol 2014; 18: 96.
Casaroto AR, Toledo GL, Toledo Filho JL, et al. Ameloblastic carcinoma, primary type: case report, immunohistochemical analysis and literature review. Anticancer Res 2012; 32: 1515-1525.
Chaisuparat R, Sawangarun W, Scheper M. A clinicopathological study of malignant odontogenic tumours. Histopathol 2012; 61: 107-112.
França DC, Moreira JM, De Aguiar SM, et al. Ameloblastic carcinoma of the maxilla: A case report. Oncol Lett 2012; 4: 1297-1300.
Horváth A, Horváth E, Popşor S., et al. Mandibular ameloblastic carcinoma in a young patient. Rom J Morphol Embryol 2012; 53: 179-183.
Jaitley S, Sivapathasundharam B. Ameloblastic carcinoma of the mandible with clear cell changes: a case report. Indian J Cancer 2013; 50: 8.
Roy S, Garg V. Alpha smooth muscle actin expression in a case of ameloblastic carcinoma: a case report. J Oral Maxillofac Res 2013: e4.
Fitzpatrick SG, Hirsch SA, Listinsky CM, et al. Ameloblastic carcinoma with features of ghost cell odontogenic carcinoma in a patient with suspected Gardner syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2015; 119: 241-245.
Kar IB, Subramanyam RV, Mishra N, et al. Ameloblastic carcinoma: A clinicopathologic dilemma – Report of two cases with total review of literature from 1984 to 2012. Ann Maxillofac Surg 2014; 4: 70.
Koca T, Başaran H, Arslan D, et al. Prominent response with helical tomotherapy in recurrent ameloblastic carcinoma of maxillary sinus: a case report. Radiation Oncol 2014; 9: 157.
Kumaran PS, Anuradha V, Gokkulakrishnan S, et al. Ameloblastic carcinoma: A case series. J Pharm Bioallied Sci 2014; 6: 208-211.
Li J, Du H, Li P, et al. Ameloblastic carcinoma: An analysis of 12 cases with a review of the literature. Oncol Lett 2014; 8: 914-920.
Ansari HA, Ray PS, Khan N, et al. Spindle-cell ameloblastic carcinoma of the maxilla with adenoid cystic carcinoma-like areas: A new variant? Indian J Pathol Microbiol 2015; 58: 513.
Uzawa N, Suzuki M, Miura C, et al. Primary ameloblastic carcinoma of the maxilla: A case report and literature review. Oncol Lett 2015; 9: 459-467.
Takahashi Y, Bandoh N, Miyamoto A, et al. Single-fraction helical tomotherapy for ameloblastic carcinoma. J Oral Maxillofac Surg 2016; 74: 302-306.
Kodati S, Majumdar S, Uppala D, et al. Ameloblastic Carcinoma: A Report of Three Cases. J Clin Diagn Res 2016; 10: 23.
Kiresur MA, Kunche A, Ananthaneni A, et al. A Rare Case Report of Spindle Cell Ameloblastic Carcinoma Involving the Mandible. J Clin Diagn Res 2017; 11: 25.
Bello IO, Alanen K, Slootweg PJ, et al. Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma. Oral Oncol 2009; 45: 760-765.
Khojasteh A, Khodayari A, Rahimi F, et al. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles. J Oral Maxillofac Surg 2013; 71: 62-65.
García-Mu¼oz A, Bologna-Molina R, Aldape-Barrios B, et al. Identification of proteins with increased levels in ameloblastic carcinoma. J Oral Maxillofac Surg 2014; 72: 1183-1196.
García-Mu¼oz A, Rodríguez MA, Licéaga-Escalera C, et al. Expression of the transcription factor PITX2 in ameloblastic carcinoma. Arch Oral Biol 2015; 60: 799-803.
Zwahlen RA, Vogt P, Fischer FS, et al. Case report: Myocardial metastasis of a maxillary malignant ameloblastoma. J Oral Maxillofac Surg 2003; 61: 731-734.
Mahmoud SA, El-Rouby DH, El-Ghani SF, et al. Correlation between ploidy status using flow cytometry and nucleolar organizer regions in benign and malignant epithelial odontogenic tumors. Arch Oral Biol 2017; 78: 94-99.
Maya R, Sekar B, Murali S. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma. Indian J Dent Res 2012; 23: 15.
Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, et al. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumor. Med Oral Patol Oral Cir Bucal 2013; 18: 174.
Carreón-Burciaga RG, González-González R, Molina-Frechero N, et al. Immunoexpression of Ki-67, MCM2, and MCM3 in ameloblastoma and ameloblastic carcinoma and their correlations with clinical and histopathological patterns. Dis Makers 2015; 2015: 683087.
Grewal HK, SetHi S. Immunohistochemical expression of type IV collagen and autocrine motility factor receptor in odontogenic tumours. J Clin Diagn Res 2014; 8: 17.
Lei Y, Jaradat JM, Owosho A, et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117: 608-16.
Kamath KP, Vidya M, Shetty N, et al. Nucleolar organizing regions and α-smooth muscle actin expression in a case of ameloblastic carcinoma. Head Neck Pathol 2010; 4: 157-162.
Safadi RA, Quda BF, Hammad HM. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2016; 121: 402-411.
Prasanna MD, Charan CR, Ealla KK, et al. Analysis of silver stained nucleolar organizing regions in odontogenic cysts and tumors. J Oral Maxillofac Surg Med Pathol 2014; 18: 45.
Da Silva AD, e Nóbrega TG, Saudades AW, et al. Ameloblastic neoplasia spectrum: a cross-sectional study of MMPS expression and proliferative activity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2016; 121: 396-401.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe